PAVmed (PAVMZ) Competitors $0.0017 0.00 (-29.79%) As of 04/25/2025 01:50 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisChartCompetitorsSEC FilingsTrendsBuy This Stock PAVMZ vs. DRTSW, ANZUW, IONM, ATAKW, BBLGW, BRSHW, BRSH, CTCXW, CRGT, and GMVDWShould you be buying PAVmed stock or one of its competitors? The main competitors of PAVmed include Alpha Tau Medical (DRTSW), Anzu Special Acquisition Corp I (ANZUW), Assure (IONM), Aurora Technology Acquisition (ATAKW), Bone Biologics (BBLGW), Bruush Oral Care (BRSHW), Bruush Oral Care (BRSH), Carmell (CTCXW), Cortigent (CRGT), and G Medical Innovations (GMVDW). These companies are all part of the "medical equipment" industry. PAVmed vs. Alpha Tau Medical Anzu Special Acquisition Corp I Assure Aurora Technology Acquisition Bone Biologics Bruush Oral Care Bruush Oral Care Carmell Cortigent G Medical Innovations PAVmed (NASDAQ:PAVMZ) and Alpha Tau Medical (NASDAQ:DRTSW) are both medical companies, but which is the superior investment? We will contrast the two businesses based on the strength of their risk, media sentiment, valuation, institutional ownership, earnings, dividends, community ranking, analyst recommendations and profitability. Does the MarketBeat Community believe in PAVMZ or DRTSW? PAVmed and Alpha Tau Medical both received 0 outperform votes by MarketBeat users. CompanyUnderperformOutperformPAVmedN/AN/AAlpha Tau MedicalN/AN/A Does the media favor PAVMZ or DRTSW? In the previous week, Alpha Tau Medical had 1 more articles in the media than PAVmed. MarketBeat recorded 2 mentions for Alpha Tau Medical and 1 mentions for PAVmed. PAVmed's average media sentiment score of 1.87 beat Alpha Tau Medical's score of 0.93 indicating that PAVmed is being referred to more favorably in the media. Company Overall Sentiment PAVmed Very Positive Alpha Tau Medical Positive Is PAVMZ or DRTSW more profitable? Company Net Margins Return on Equity Return on Assets PAVmedN/A N/A N/A Alpha Tau Medical N/A N/A N/A Which has preferable valuation & earnings, PAVMZ or DRTSW? CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioPAVmed$3.00MN/AN/AN/AN/AAlpha Tau MedicalN/AN/AN/AN/AN/A SummaryPAVmed beats Alpha Tau Medical on 2 of the 3 factors compared between the two stocks. Get PAVmed News Delivered to You Automatically Sign up to receive the latest news and ratings for PAVMZ and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart PAVMZ vs. The Competition Export to ExcelMetricPAVmedMedical Devices IndustryMedical SectorNASDAQ ExchangeMarket CapN/A$3.16B$5.44B$7.80BDividend YieldN/A2.45%5.43%4.31%P/E RatioN/A66.2822.1418.40Price / SalesN/A117.42389.71101.29Price / CashN/A15.9938.2034.62Price / BookN/A3.666.664.18Net IncomeN/A$126.02M$3.21B$247.71M7 Day PerformanceN/A0.21%6.21%6.61%1 Month PerformanceN/A-7.84%-2.82%-2.21%1 Year PerformanceN/A-14.94%16.44%4.68% PAVmed Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)PAVMZPAVmedN/A$0.00-29.8%N/A-91.8%$0.00$3.00M0.0090Positive NewsDRTSWAlpha Tau MedicalN/A$0.21+2.7%N/A+18.9%$0.00N/A0.0080News CoveragePositive NewsANZUWAnzu Special Acquisition Corp IN/A$0.03flatN/A-82.3%$0.00N/A0.002IONMAssureN/AN/AN/AN/A$0.00$149,000.000.00130News CoverageATAKWAurora Technology AcquisitionN/A$0.01-5.0%N/A-66.0%$0.00N/A0.00N/AGap DownBBLGWBone BiologicsN/A$20.20-2.9%N/A-26.6%$0.00N/A0.002Gap DownBRSHWBruush Oral CareN/AN/AN/AN/A$0.00$2.92M0.0011Positive NewsBRSHBruush Oral CareN/A$0.00+12.5%N/A-98.6%$0.00$2.92M0.0011Gap UpCTCXWCarmellN/A$0.03+6.8%N/A-70.3%$0.00$32,839.000.0014Gap UpCRGTCortigentN/AN/AN/AN/A$0.00N/A0.006High Trading VolumeGMVDWG Medical InnovationsN/AN/AN/AN/A$0.00$4.42M0.0072 Related Companies and Tools Related Companies Alpha Tau Medical Alternatives Anzu Special Acquisition Corp I Alternatives Assure Alternatives Aurora Technology Acquisition Alternatives Bone Biologics Alternatives Bruush Oral Care Alternatives Bruush Oral Care Alternatives Carmell Alternatives Cortigent Alternatives G Medical Innovations Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:PAVMZ) was last updated on 4/26/2025 by MarketBeat.com Staff From Our PartnersDonald Trump is about to free crypto from its chains …Sure enough, Bitcoin took off on the exact day Juan said it would. It's up more than 40% since the election...Weiss Ratings | SponsoredTrump’s tariffs just split the AI market in twoTrump’s tariff just split the AI market – among others – in two. One group of AI companies—the ones relying...Traders Agency | SponsoredSilicon Valley Gold RushA new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | SponsoredWhy Elon put $51 million into thisWhy Elon Musk Just Invested $51 Million Into Brand New “Miracle Metal” Developed by MIT ScientistsTrue Market Insiders | SponsoredGold Alert: The Truth About Fort Knox Is ComingOwning physical gold isn’t the best way to profit. I’ve found a better way to invest in gold—one that’s alr...Golden Portfolio | SponsoredJames Altucher: Do not invest in AI unless…I made millions during the crypto boom. Many “experts” are now saying… Artificial Intelligence opportuni...Paradigm Press | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowThe July 23rd Crypto Trigger Could Mark the Beginning of Bitcoin’s Next Big Move Bitcoin’s early 2024 ETF r...Crypto Swap Profits | SponsoredIt’s absolute chaos in Silicon Valley right now…If you missed out on the big boom in Nvidia… Listen up, because according to Nvidia's own CEO… Elon Musk...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding PAVmed Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share PAVmed With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy PAVMZ Stock Free PAVMZ Stock Alerts